192 related articles for article (PubMed ID: 31438566)
1. Long-Term Physical (In)Stability of Spray-Dried Amorphous Drugs: Relationship with Glass-Forming Ability and Physicochemical Properties.
Edueng K; Bergström CAS; Gråsjö J; Mahlin D
Pharmaceutics; 2019 Aug; 11(9):. PubMed ID: 31438566
[TBL] [Abstract][Full Text] [Related]
2. Crystallization tendency of APIs possessing different thermal and glass related properties in amorphous solid dispersions.
Kapourani A; Vardaka E; Katopodis K; Kachrimanis K; Barmpalexis P
Int J Pharm; 2020 Apr; 579():119149. PubMed ID: 32070762
[TBL] [Abstract][Full Text] [Related]
3. Early drug development predictions of glass-forming ability and physical stability of drugs.
Mahlin D; Bergström CA
Eur J Pharm Sci; 2013 May; 49(2):323-32. PubMed ID: 23557841
[TBL] [Abstract][Full Text] [Related]
4. Physical stability of drugs after storage above and below the glass transition temperature: Relationship to glass-forming ability.
Alhalaweh A; Alzghoul A; Mahlin D; Bergström CAS
Int J Pharm; 2015 Nov; 495(1):312-317. PubMed ID: 26341321
[TBL] [Abstract][Full Text] [Related]
5. Influence of Glass Forming Ability on the Physical Stability of Supersaturated Amorphous Solid Dispersions.
Blaabjerg LI; Bulduk B; Lindenberg E; Löbmann K; Rades T; Grohganz H
J Pharm Sci; 2019 Aug; 108(8):2561-2569. PubMed ID: 30878513
[TBL] [Abstract][Full Text] [Related]
6. Characterization of Phase Separation Propensity for Amorphous Spray Dried Dispersions.
McNamara D; Yin S; Pan D; Crull G; Timmins P; Vig B
Mol Pharm; 2017 Feb; 14(2):377-385. PubMed ID: 28068097
[TBL] [Abstract][Full Text] [Related]
7. Myth or Truth: The Glass Forming Ability Class III Drugs Will Always Form Single-Phase Homogenous Amorphous Solid Dispersion Formulations.
Panini P; Rampazzo M; Singh A; Vanhoutte F; Van den Mooter G
Pharmaceutics; 2019 Oct; 11(10):. PubMed ID: 31614985
[TBL] [Abstract][Full Text] [Related]
8. Improved Physical Stability and Aerosolization of Inhalable Amorphous Ciprofloxacin Powder Formulations by Incorporating Synergistic Colistin.
Shetty N; Ahn P; Park H; Bhujbal S; Zemlyanov D; Cavallaro A; Mangal S; Li J; Zhou QT
Mol Pharm; 2018 Sep; 15(9):4004-4020. PubMed ID: 30028947
[TBL] [Abstract][Full Text] [Related]
9. A classification system to assess the crystallization tendency of organic molecules from undercooled melts.
Baird JA; Van Eerdenbrugh B; Taylor LS
J Pharm Sci; 2010 Sep; 99(9):3787-806. PubMed ID: 20623696
[TBL] [Abstract][Full Text] [Related]
10. Melt extrusion vs. spray drying: The effect of processing methods on crystalline content of naproxen-povidone formulations.
Haser A; Cao T; Lubach J; Listro T; Acquarulo L; Zhang F
Eur J Pharm Sci; 2017 May; 102():115-125. PubMed ID: 28259831
[TBL] [Abstract][Full Text] [Related]
11. Preparation and characterization of spray-dried co-amorphous drug-amino acid salts.
Jensen KT; Blaabjerg LI; Lenz E; Bohr A; Grohganz H; Kleinebudde P; Rades T; Löbmann K
J Pharm Pharmacol; 2016 May; 68(5):615-24. PubMed ID: 26245703
[TBL] [Abstract][Full Text] [Related]
12. Amorphism and physicochemical stability of spray-dried frusemide.
Matsuda Y; Otsuka M; Onoe M; Tatsumi E
J Pharm Pharmacol; 1992 Aug; 44(8):627-33. PubMed ID: 1359084
[TBL] [Abstract][Full Text] [Related]
13. Glass-forming ability of compounds in marketed amorphous drug products.
Wyttenbach N; Kuentz M
Eur J Pharm Biopharm; 2017 Mar; 112():204-208. PubMed ID: 27903457
[TBL] [Abstract][Full Text] [Related]
14. Physicochemical properties of amorphous clarithromycin obtained by grinding and spray drying.
Yonemochi E; Kitahara S; Maeda S; Yamamura S; Oguchi T; Yamamoto K
Eur J Pharm Sci; 1999 Mar; 7(4):331-8. PubMed ID: 9971917
[TBL] [Abstract][Full Text] [Related]
15. Influence of preparation pathway on the glass forming ability.
Blaabjerg LI; Lindenberg E; Rades T; Grohganz H; Löbmann K
Int J Pharm; 2017 Apr; 521(1-2):232-238. PubMed ID: 28232267
[TBL] [Abstract][Full Text] [Related]
16. Physicochemical stability of crystalline sugars and their spray-dried forms: dependence upon relative humidity and suitability for use in powder inhalers.
Naini V; Byron PR; Phillips EM
Drug Dev Ind Pharm; 1998 Oct; 24(10):895-909. PubMed ID: 9876544
[TBL] [Abstract][Full Text] [Related]
17. An investigation into the crystallization tendency/kinetics of amorphous active pharmaceutical ingredients: A case study with dipyridamole and cinnarizine.
Baghel S; Cathcart H; Redington W; O'Reilly NJ
Eur J Pharm Biopharm; 2016 Jul; 104():59-71. PubMed ID: 27108783
[TBL] [Abstract][Full Text] [Related]
18. Amino acids as stabilizers for spray-dried simvastatin powder for inhalation.
Lu W; Rades T; Rantanen J; Chan HK; Yang M
Int J Pharm; 2019 Dec; 572():118724. PubMed ID: 31678523
[TBL] [Abstract][Full Text] [Related]
19. A study of the differences between two amorphous spray-dried samples of cefditoren pivoxil which exhibited different physical stabilities.
Ohta M; Buckton G
Int J Pharm; 2005 Jan; 289(1-2):31-8. PubMed ID: 15652196
[TBL] [Abstract][Full Text] [Related]
20. A comparative study between hot-melt extrusion and spray-drying for the manufacture of anti-hypertension compatible monolithic fixed-dose combination products.
Kelleher JF; Gilvary GC; Madi AM; Jones DS; Li S; Tian Y; Almajaan A; Senta-Loys Z; Andrews GP; Healy AM
Int J Pharm; 2018 Jul; 545(1-2):183-196. PubMed ID: 29730176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
